Related by context. All words. (Click for frequent words.) 81 CI #.#-#.# [002] 80 confidence interval CI 78 % CI #.#-#.# [008] 78 % CI #.#-#.# [006] 77 % CI #.#-#.# [003] 77 % Confidence Interval 77 CI -#.# 76 % CI #.#-#.# [002] 76 % CI #.#-#.# [007] 75 multivariable adjusted 74 CI = 74 % CI #.#-#.# [001] 74 lowest tertile 74 advanced adenoma 73 p = .# [002] 72 confidence intervals CIs 72 P = .# 72 CC genotype 72 CI #.#-#.# [001] 72 colorectal adenoma 72 mL/min/#.# m 2 71 % CI #.#-#.# [004] 71 aOR 71 P ≤ 70 AOR = 70 nonfatal MI 70 x ULN 70 ALT elevation 70 polyp recurrence 70 oxycodone CR 70 highest tertile 69 creatinine ratio 69 hip BMD 69 -#.# ± [002] 69 nondiabetic patients 69 TAXUS p value 69 μmol L 69 TT genotype 69 highest quintile 69 Hazard Ratio HR 69 adjunctive placebo 69 nonsignificant difference 69 FOLFIRI alone 69 p ≤ 68 SGPT 68 BRCA1 mutation carriers 68 MetS 68 recurrent venous thromboembolism 68 CVD mortality 68 nonobese 68 p = NS 68 pT3 68 mU liter 68 recurrent VTE 68 advanced adenomas 68 achieved ACR# 68 pmol L 68 arterial thromboembolic events 68 adjunctive ABILIFY 67 locoregional recurrence 67 reinfarction 67 NMIBC 67 HBeAg negative patients 67 #.#/#.# mmHg [001] 67 overt nephropathy 67 advanced neoplasia 67 PSA nadir 67 multivariate adjusted 67 invasive lobular 67 neurodevelopmental impairment 67 biochemical relapse 67 nondiabetic 67 pg ml 67 hypophosphatemia 67 parous women 67 interquartile range 67 perimenopausal women 67 -#.# mg dL [001] 67 univariate analysis 67 intact parathyroid hormone 67 binary restenosis 67 colorectal neoplasia 67 endometrial thickness 67 invasive carcinomas 67 multivariate adjustment 66 HOMA IR 66 biochemical recurrence 66 histologic subtype 66 alanine aminotransferase 66 mIU ml 66 femoral neck BMD 66 LV dysfunction 66 mIU L 66 HbA 1c levels 66 HbA1C levels 66 fasting triglyceride levels 66 preoperative PSA 66 diabetes mellitus DM 66 postoperative AF 66 seropositivity 66 mmol l 66 generalized edema 66 lopinavir r arm 66 KRAS mutations occur 66 tolterodine ER 66 nonfatal stroke 66 tertile 66 NNT = 66 collagenous colitis 66 leukopenia 66 multivariate Cox 66 transferrin saturation 66 hypertension diabetes mellitus 66 univariate analyzes 66 receiving ISENTRESS 66 glycated hemoglobin levels 66 β = 66 subclinical hyperthyroidism 66 morphometric vertebral fractures 65 nonvertebral fractures 65 Ishak fibrosis score 65 rs# [002] 65 nmol liter 65 TEAEs 65 â ‰ ¥ 65 recurrent atrial fibrillation 65 baseline HbA1c 65 nmol l 65 baseline serum creatinine 65 placebo p = 65 recurrent acute pancreatitis 65 tertiles 65 = #.#-#.# 65 intima media thickness 65 euthyroid 65 endometrial hyperplasia 65 mmHg diastolic 65 statistically significant p = 65 #.#mg/dL 65 odds ratios ORs 65 % CI #.#-#.# [005] 65 p = 65 mg BID dose 65 mmol liter 65 nondiabetics 65 mild renal insufficiency 65 hyperlipemia 65 postoperative delirium 65 pmol liter 65 carotid stenosis 65 #.#ng/ml 65 nmol 65 #.#-#.# p = 65 alanine aminotransferase ALT 65 infliximab monotherapy 65 chlorambucil 65 MMSE score 65 CI #.#-#.# p = 65 tirofiban 65 nonfatal myocardial infarction 65 inversely associated 65 adenoma recurrence 65 thyrotropin levels 65 PROCTOCORT ® Suppository Hydrocortisone 65 5-FU/LV 65 nadroparin 64 p = #.# [003] 64 invasive ductal 64 prednisone prednisolone plus 64 prostate cancer CaP 64 oxycodone IR 64 amoxicillin clavulanate 64 recurrent UTI 64 CR nPR 64 % AST SGOT 64 HIV uninfected 64 MADRS score 64 definite stent thrombosis 64 lispro 64 Acetate Rectal Suppositories 64 COPD exacerbation 64 hemoglobin A1c HbA1c 64 mmHg p = 64 flutamide 64 Arch Intern Med 64 hydroxyvitamin D levels 64 nonsignificant 64 vertebral fracture 64 quetiapine risperidone 64 umol L 64 doxazosin 64 ‰ ¥ 64 statistical significance p 64 carotid IMT 64 beta carotene supplementation 64 extracapsular extension 64 tumor histology 64 progesterone receptor negative 64 noncarriers 64 PREZISTA r arm 64 Hazard Ratio = 64 mg p = 64 sirolimus stent 64 overt hepatic encephalopathy HE 64 serum estradiol 64 log# copies mL 64 T1c 64 β blockers 64 Flu Cy 64 perioperatively 64 Operative mortality 64 neoplasias 64 #.#/#.# mm Hg [003] 64 salmeterol fluticasone propionate 64 elevated lipase 64 latent celiac disease 64 abdominal irradiation 64 histologically confirmed 64 heterozygotes 64 REYATAZ r arm 64 pg mL 64 elevated LDH 64 obstructive coronary artery 64 achieved statistical significance 64 p = .# [001] 64 thrombocytopenic 64 neutropenic sepsis 64 PRADAXA #mg 64 multivariable analysis 64 elevated ALT 64 methotrexate monotherapy 64 μg L 64 metastatic GIST 64 underwent surgical resection 64 hormone receptor negative 64 leucopenia 64 -#.# mg dL [002] 64 bronchioloalveolar carcinoma 64 postoperative complication 64 LVSD 64 Folfox 64 mcg QD 64 aged ≥ 64 nonalcoholic steatohepatitis NASH 64 nonfasting triglyceride levels 64 nicardipine 64 endometrial carcinoma 64 noncardiac 64 metastatic malignant 64 CIN2 + 64 elevated transaminases 64 -#.# log# copies mL 64 ATACAND 64 mL/min/#.# m2 64 pCR 64 Stent thrombosis 64 lumbar spine BMD 64 PSADT 63 XIENCE V vs. 63 impaired glucose metabolism 63 leukocyte count 63 HF hospitalization 63 rs# [001] 63 macroalbuminuria 63 receiving VICTRELIS 63 GG genotype 63 elevated triglyceride levels 63 Breslow thickness 63 titrated glipizide 63 HBeAg negative 63 serum urate levels 63 distant metastasis 63 aspartate aminotransferase 63 recurrent DVT 63 acute cholecystitis 63 lobular cancer 63 elevated IOP 63 CrCl 63 posttransplant 63 atopic asthma 63 Univariate analysis 63 pretest probability 63 colorectal adenomas 63 severe neutropenia 63 certolizumab 63 endometriosis ovarian cysts 63 oral antidiabetic medication 63 allergic eczema 63 ipsilateral stroke 63 urine albumin 63 relapsed MM 63 logistic regression analysis 63 Papillary 63 Hazard Ratio 63 interleukin IL -6 63 ischemia driven 63 nmol L 63 hyperhomocysteinemia 63 histological subtype 63 Adjuvant chemotherapy 63 undergone radical prostatectomy 63 HbA 1c 63 atazanavir ritonavir 63 tHcy 63 CIN3 63 bronchial hyperresponsiveness 63 deep venous thromboses 63 ertapenem 63 apolipoprotein B 63 hematopoietic cancers 63 malignancy HCM 63 #-#,# mg 63 ECOG PS 63 fatigue asthenia 63 pre eclamptic 63 PCa 63 dysuria 63 BMI z 63 ß blockers 63 glipizide plus 63 affective psychosis 63 ug dose 63 adenomatous polyps 63 #.#g/day 63 nonvertebral fracture 63 Doxil ® 63 contrast induced nephropathy 63 postintervention 63 ß = 63 nonobese patients 63 hepatorenal syndrome 63 rs# [003] 63 atypical hyperplasia 63 #q# deletion syndrome 63 antiretroviral naïve 63 PLX STROKE targeting 63 Prognostic significance 63 homozygotes 63 abacavir lamivudine 63 mm Hg diastolic 63 NNRTI resistance 63 Hb A1C 63 stage IIIb IV 63 PaO 2 63 conjunctival hyperemia 63 microbiological eradication 63 thromboembolic complications 63 hepatocellular carcinomas 63 anthracycline containing 63 carotid artery intima media 63 EGFR mutation positive 63 lifetime abstainers 63 urinary bladder cancer 63 Complication rates 63 rs# [004] 63 pooled comparator 63 kg m² 62 venlafaxine Effexor 62 SUVmax 62 p = #.# [004] 62 Thal Dex 62 T2DM 62 CYP#D# inhibitor 62 tibiofemoral 62 BRCA2 carriers 62 albumin excretion rate 62 postop 62 #.#mmol L [002] 62 Zometa hazard 62 #ng/ml 62 revascularizations 62 μg dL 62 gastric cardia 62 elevated hsCRP 62 metoprolol tartrate 62 graft occlusion 62 onset diabetes mellitus 62 periprocedural 62 rheumatoid factor 62 elevated LDL cholesterol 62 pT2 62 μg g 62 QIDS SR 62 g dl 62 elevated depressive symptoms 62 biopsy Gleason 62 microalbuminuria 62 hours postdose 62 XIENCE V PROMUS Stent 62 haematologic 62 BMI ≥ 62 echocardiographic parameters 62 FluCAM arm 62 thromboembolic 62 ovarian carcinoma 62 GSTP1 62 hydroxymethyl coenzyme 62 liver histology 62 pretransplant 62 colon rectal 62 cervix uteri 62 annualized relapse 62 elevated alkaline phosphatase 62 rizatriptan 62 underwent resection 62 nonmetastatic 62 clodronate 62 osteopenic 62 p = #.# [002] 62 μg d 62 benazepril 62 nonischemic 62 #Gy 62 rebleeding 62 atrophic gastritis 62 Secondary endpoints included 62 idiopathic PAH 62 operable breast cancer 62 spine BMD 62 nmol L. 62 isoprostane 62 XIENCE V demonstrated 62 PREMPRO 62 elevated serum creatinine 62 severe exacerbations 62 carotid intima media 62 protein excretion 62 cutaneous melanoma 62 salmeterol HFA MDI 62 sd = 62 regression coefficient 62 NPH insulin 62 placebo dexamethasone 62 mU L 62 adiponectin concentrations 62 HGPIN 62 hypercalciuria 62 thromboembolism 62 mmHg systolic 62 cerebral infarction 62 erythrocyte sedimentation rate 62 nonpregnant women 62 receiving VELCADE 62 underwent CABG 62 distal colon cancer 62 DAS# remission 62 μg liter 62 K ras mutations 62 psychiatric comorbidities 62 microbiologically evaluable 62 Mg Uk 62 postmenopausal osteoporotic women 62 ASCUS 62 HNSCC 62 enamel defects 62 n = 62 See WARNINGS 62 pentoxifylline 62 insomnia somnolence 62 FOLFOX4 62 diastolic BP 62 mg kg Hematide 62 CHD mortality 62 #mmHg [002] 62 bivalirudin monotherapy 62 fasting insulin 62 AUC0 62 serum selenium 62 TMP SMX 62 Serum creatinine 62 cGy 62 abnormal lipid 62 transaminase elevations 62 tamoxifen Nolvadex ® 62 myelodysplastic myeloproliferative diseases 62 preintervention 62 testicular tumors 62 μg kg 62 glulisine 62 fluticasone salmeterol 62 median survivals 62 NAT2 62 patients undergoing CABG 62 smoldering myeloma 62 extensive metabolizers 62 apolipoprotein E4 62 LV ejection fraction 62 logistic regression model 62 gestational hypertension 62 seminal vesicle invasion 62 proband 62 URTI 62 comparator arm 62 serum creatinine levels 62 subclinical atherosclerosis 62 HbA1C 62 node metastases 62 mm Hg systolic 62 autoantibody positive 62 cyclophosphamide methotrexate 62 oral squamous cell 62 trimethoprim sulfamethoxazole 62 mild renal impairment 62 MMSE scores 62 #mg BID [001] 62 4mg/kg 61 smoldering multiple myeloma 61 -#.# log# 61 hypovitaminosis D 61 #mmHg [001] 61 plasma adiponectin 61 HBeAg 61 BRCA2 mutation carriers 61 plus dexamethasone 61 dapagliflozin plus 61 nondepressed 61 plasma folate 61 8mg/kg 61 atheroma volume 61 baseline LDH 61 comorbid anxiety 61 troponin T 61 CR CRu 61 spontaneous bacterial peritonitis 61 cerebrovascular events 61 undergoing radical cystectomy 61 prolonged QT interval 61 hyperparathyroidism 61 plus medroxyprogesterone acetate 61 colonic polyps 61 SLNB 61 Erythropoietic therapies may 61 shorter telomere length 61 corticosteroid dose 61 lymphocytosis 61 adnexal mass 61 IM progesterone 61 Fasting plasma glucose 61 mcg dL 61 Infusion Reactions Severe 61 lacunar 61 #OHD 61 seroconverted 61 clinically evaluable patients 61 eplerenone 61 linoleic acid LA 61 subclinical hypothyroidism 61 BMS p = 61 r2 = 61 univariate 61 metastatic gastric 61 lowest quintile 61 androgen suppression 61 mean baseline A1C 61 aspartate aminotransferase AST 61 de novo AML 61 diastolic hypertension 61 plasma homocysteine 61 FDG uptake 61 complete cytogenetic response 61 thromboembolisms 61 HLA DRB1 61 renal scarring 61 serum concentrations 61 gallbladder disease 61 MACCE 61 coronary artery calcification 61 posttreatment 61 HER2 overexpression 61 external genital lesions 61 IPAH 61 urolithiasis 61 cisplatin vinorelbine 61 serum IGF 61 aspirin clopidogrel 61 progression TTP 61 UGT#A# * 61 HBeAg seroconversion 61 mmol L 61 systolic hypertension 61 titrated glipizide plus 61 triglyceride concentrations 61 statistically significant p 61 squamous histology 61 lumbar spine bone 61 #mg/dL [001] 61 systolic dysfunction 61 mEq L 61 neutrophil counts 61 unresectable HCC 61 normotensive 61 mcg albinterferon alfa 2b 61 intravesical therapy 61 mcg BID 61 oral hypoglycemic agent 61 prostate carcinoma 61 nondrinkers 61 HER2 expression 61 mEq 61 leiomyomas 61 ductal cancer 61 refractory ischemia 61 triiodothyronine 61 Cream USP 1 61 dalteparin 61 IDDM 61 systemic corticosteroid 61 chlorthalidone 61 WOMAC pain 61 #mg/dL [002] 61 serum CRP 61 noninferior 61 arterial thickening 61 severe renal impairment 61 peripheral sensory neuropathy 61 ALT normalization 61 #.#mmol L [001] 61 attain statistical significance 61 Subgroup analysis 61 nonfatal myocardial infarction MI 61 familial aggregation 61 paroxysmal AF 61 autonomic dysfunction 61 cervical intraepithelial neoplasia 61 asthenia fatigue 61 aortic atherosclerosis 61 grade cervical intraepithelial 61 elevated fasting glucose 61 advanced hepatocellular carcinoma 61 hsCRP levels 61 atherogenic dyslipidemia 61 liver metastasis 61 del 5q MDS 61 p = ns 61 CK # plasma concentrations 61 #OHD levels 61 baseline FEV 61 #.#/# [005] 61 Postoperative complications 61 HBeAg positive patients 61 triacylglycerol concentrations 61 serum homocysteine 61 comorbidity 61 Kaplan Meier analysis 61 radical prostatectomy RP 61 cough dyspnea 61 EpCAM expression 61 Avandia Actos 61 NIH CPSI 61 GH deficiency 61 cirrhotic 61 placebo p 61 mg + GLY 61 T1a 61 achieved mucosal healing 61 pyrexia mucositis sepsis febrile 61 nonfasting 61 cardiovascular mortality 61 non splenectomized 61 virologic failure 61 BARACLUDE ® 61 nulliparous women 61 tipranavir r 61 BRCA mutation carriers 61 systolic BP 61 noncardiovascular mortality 61 chorioamnionitis 61 oesophageal adenocarcinoma 61 atopic 61 antiandrogen 60 asthma exacerbation 60 rho = 60 #mg BID [003] 60 ischemic lesions 60 abnormal glucose tolerance 60 axillary node 60 nonobstructive 60 uM 60 LH FSH 60 poor metabolizers 60 initiating antiretroviral therapy 60 recurrent metastatic 60 TAXUS Express Stent 60 Partial Responses 60 mutated K ras 60 Plasma concentrations 60 colorectal carcinoma 60 idraparinux 60 HIV coinfected 60 bronchopulmonary dysplasia 60 ≥ 60 papillary renal cell carcinoma 60 adenomatous 60 mucinous 60 ALT flares 60 ErbB2 positive 60 reflux esophagitis 60 Depressive symptoms 60 Heavy menstrual bleeding 60 precancerous cervical 60 venous thrombosis 60 urinary albumin 60 5-fluorouracil/leucovorin 60 lamivudine refractory patients 60 μg mL 60 VLBW 60 adefovir treated 60 symptomatic intracerebral hemorrhage 60 FDA defined valvulopathy 60 cytarabine daunorubicin 60 coronary stenosis 60 dyspareunia 60 mg d 60 HbA1c levels 60 non valvular atrial 60 contralateral breast cancer 60 recurrent myocardial infarction 60 resectable pancreatic cancer 60 grade squamous intraepithelial 60 lactate dehydrogenase 60 unresectable tumors 60 Radical prostatectomy 60 POAG 60 IOP lowering 60 vulvovaginal atrophy 60 coronary calcification 60 myocardial infarctions MIs 60 biphasic insulin aspart 60 IIIa inhibitors 60 venous thromboembolic disease 60 receiving XGEVA 60 carotid plaques 60 gene polymorphism 60 heFH 60 gynecologic malignancy 60 hemoglobin A1c levels 60 Nonalcoholic fatty liver 60 ARCOXIA 60 carotid artery blockage 60 diabetes mellitus hypertension 60 headache nasopharyngitis 60 variceal bleeding 60 naïve HCV 60 renal cell carcinomas 60 mcg kg REBETOL 60 segment binary restenosis 60 malignant neoplasm 60 HER2 amplification 60 BUPHENYL R sodium phenylbutyrate 60 glycated hemoglobin HbA1c 60 linaclotide treated 60 adriamycin 60 primary hypercholesterolemia 60 gestational diabetes mellitus GDM 60 Pred Forte 60 comorbid 60 Impaired glucose tolerance 60 chronic prostatitis 60 GSTT1 60 CCyR 60 undergoing coronary angiography 60 colorectum 60 preterm neonates 60 endarterectomy 60 fibroids endometriosis 60 folate concentrations 60 nodal metastasis 60 SCr 60 nephrolithiasis 60 pulmonary dysfunction 60 postoperative pulmonary 60 death reinfarction 60 habitual snoring 60 glucuronide 60 radical nephrectomy 60 severe periodontitis 60 #.#-#.# [011] 60 lopinavir r 60 hyperlipidaemia 60 moderate renal impairment 60 isolated systolic hypertension 60 asymptomatic PAD 60 dysglycemia 60 KRAS wild 60 noncardiovascular 60 TP# mutations 60 atopy 60 variceal hemorrhage 60 elevated creatinine 60 hypokalemia 60 obstructive CAD 60 placebo fluoxetine 60 incidence ≥ 60 underwent radical prostatectomy 60 metastatic pancreatic 60 adverse reactions incidence 60 mucosal inflammation 60 arterial oxygen saturation 60 ductal carcinomas 60 thromboembolic disease 60 mcg linaclotide 60 symptomatic VTE 60 acarbose 60 elevated LDL 60 ug ml 60 undergoing radical prostatectomy 60 #mg/day [001] 60 serum triglycerides 60 prevalences 60 mg TID 60 perioperative complications 60 moderately emetogenic 60 atherosclerotic CVD 60 imiquimod cream 60 rFSH 60 CHD CVD 60 Endometrial 60 alpha1 antitrypsin AAT deficiency 60 mg ustekinumab 60 colorectal neoplasms 60 intracranial atherosclerosis 60 gross hematuria 60 fluorouracil leucovorin 60 NATRECOR R 60 neutropenia dehydration dyspnea 60 Invasive Breast Cancer 60 Triamcinolone 60 QTcF 60 ml kg 60 Index CDAI 60 spontaneous preterm birth 60 asymptomatic carotid stenosis 60 tapentadol ER 60 postoperative mortality 60 statistically significant predictor 60 recurrent glioblastoma multiforme 60 preoperative chemotherapy 60 neuropathy sensory 60 tamsulosin 60 anthracycline taxane 60 J Am Coll 60 HER2 positive cancers 60 serum ferritin 60 renal insufficiency 60 candesartan cilexetil 60 dietary calcium intake 60 log# IU mL 60 #q# deletion 60 tibolone 60 total thyroidectomy 60 pancreatic prostate 60 -#.# mmol L 60 CIN3 + 60 bioavailable testosterone 60 serum cortisol 60 Mg Usa 60 laboratory abnormalities 60 mycophenolate 60 radiotherapy RT 60 lipid abnormalities 60 -#.# ± [001] 60 coinfected 60 nonmelanoma skin cancer 60 Fasting blood glucose 60 fluticasone propionate FP 60 sociodemographic characteristics 60 -#.# p = 60 chlamydial infection 60 FUSILEV enhances 60 Secondary endpoints include 60 venlafaxine XR 60 fructosamine 60 mRCC 60 hemorrhagic complications 60 β blocker 60 clomipramine 60 hypertensives 60 Helicobacter pylori infection 60 oral allopurinol 60 postoperative morbidity 60 lobular breast cancer 60 hypogonadal 60 adverse reactions occurring 60 primary aldosteronism 60 Uterine cancer 60 serum lipid levels 60 mg/m2 dose 60 VaD 60 plasma homocysteine levels 60 pamidronate 60 headache abdominal pain 60 conjugated equine estrogens 60 basal cell carcinoma BCC 60 prostatic adenocarcinoma 60 hemodynamically significant 60 μg doses 60 creatinine clearance 60 conjugated equine estrogen 60 HIV seronegative 60 CP CPPS 60 df = 60 elevated uric acid 60 achieved CCyR 60 ejection fractions 60 PAOD 60 efavirenz EFV 60 macrovascular events 60 tranylcypromine 60 prostate cancer PCa 60 comorbid illnesses 60 XELOX 59 baseline Hb 59 bilateral oophorectomy 59 systolic blood pressures 59 nausea somnolence 59 VELCADE melphalan 59 nadolol 59 budesonide pMDI 59 Febrile neutropenia 59 elevated CRP 59 oral Hycamtin 59 aminotransferase elevations greater 59 anemia hemoglobin 59 cytogenetic abnormalities 59 multivariate analyzes 59 lobular carcinoma 59 microg 59 fructose intolerance 59 bisoprolol 59 sulphonylureas 59 mg QD 59 Adenomas 59 prospectively stratified 59 serum aminotransferase levels 59 sUA 59 baseline A1C 59 lymph node metastasis 59 undetectable HBV DNA 59 ACR# ACR# 59 Multivariate analysis showed 59 BENICAR HCT 59 anaplastic astrocytomas 59 CaP 59 Xalatan R 59 induce orthostatic hypotension 59 serum magnesium 59 = .# 59 pheochromocytoma 59 virological failure 59 nodal metastases 59 liver transplant recipients 59 plus GP IIb 59 ADPKD 59 CHADS2 59 thyroid carcinoma 59 response pCR 59 dyslipidaemia 59 Ann Intern Med 59 Am J Cardiol 59 ng dL 59 leukemia AML 59 CLL SLL 59 nonmelanoma skin cancers 59 urinary N telopeptide 59 pancreatic fistula 59 CIMZIA TM certolizumab pegol 59 ATV RTV 59 mg qd 59 epithelial ovarian cancer 59 μg dl 59 hypercholesterolaemia 59 serum PTH 59 dehydroepiandrosterone sulfate 59 paresthesias 59 thiopurine 59 estimated GFR 59 AST ALT 59 myocardial infarction stroke 59 daunorubicin 59 periprocedural MI 59 nontraumatic 59 serum PSA 59 fasting triglycerides 59 affective psychoses 59 hematuria 59 atopic disorders 59 tPSA 59 APOE e4 59 2 diabetes T2D 59 postoperative chemotherapy 59 imipenem 59 TURBT 59 clinically meaningful reductions 59 experienced virologic failure 59 receiving INTRON 59 μg ml 59 perianal 59 breast endometrial 59 bladder carcinoma